Search Results - Minal Barve

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6 by Vedin Barve, Ned Adams, Laura Stanbery, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Minal Barve, John Nemunaitis

    Published in Vaccines (2021-10-01)
    Get full text
    Article


  2. 2

    Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (202... by Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi

    Published in Gynecologic Oncology Reports (2021-05-01)
    Get full text
    Article


  3. 3

    726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study by Minal Barve, Ahmad A Tarhini, Deepak Kilari, Randy Sweis, Timothy Yap, John Clark, Justin Gainor, Lu Gan, Ulka N Vaishampayan, Amna Sher, Yawen Ju, Susan Henry, Stephen DeWall, Asia McCune, Mo Qatanani

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  4. 4

    666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients by Minal Barve, Ahmad A Tarhini, Deepak Kilari, Rana Mckay, Randy Sweis, Timothy Yap, Justin Gainor, Raghad Karim, Lu Gan, Lan Liu, David Park, Ulka N Vaishampayan, Amna Sher, Sunil Babu, Yawen Ju, Susan Henry

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  5. 5

    Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer by Jonathan W. Goldman, Minal Barve, Jyoti D. Patel, Antoinette Wozniak, Afshin Dowlati, Alexander Starodub, Taofeek K. Owonikoko, William Edenfield, Scott A. Laurie, Daniel Da Costa, Satwant Lally, Martina Koch, Matthew P. Kosloski, David Hoffman, Grace K. Dy

    Published in Clinical and Translational Science (2021-03-01)
    Get full text
    Article


  6. 6

    Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors by Agostina Stradella, Melissa Johnson, Sanjay Goel, Haeseong Park, Nehal Lakhani, Hendrik‐Tobias Arkenau, Matthew D. Galsky, Emiliano Calvo, Vicente Baz, Victor Moreno, Omar Saavedra, Stephen J. Luen, Song Mu, Qiting Wan, Victoria Chang, Wa Zhang, Minal Barve

    Published in Cancer Medicine (2024-07-01)
    Get full text
    Article


  7. 7

    652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors by Cara Haymaker, Aung Naing, Minal Barve, Marya Chaney, Se Hwan Yang, Siyoung Lee, Byung Ha Lee, Sara Ferrando-Martinez, Hirva Mamdani, Richard D Kim, Meredith Pelster, Mohamed Derbala, Jack Goon, Samuel Darko, Julie Murphy, Lauren Gorelik, Allison Bierly

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  8. 8

    Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer by Afshin Dowlati, Judy Wang, Siqing Fu, Amita Patnaik, Minal Barve, Shivaani Kummar, Abdul Rafeh Naqash, Patricia LoRusso, Michael Gordon, Debra L Richardson, Ira Winer, Christos Kyriakopoulos, Joleen Hubbard, Marc Chamberlain, Oladapo O Yeku, Winston W Tan, Sarah K Lynam

    Published in Journal for ImmunoTherapy of Cancer (2025-03-01)
    Get full text
    Article


  9. 9

    Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid... by Joaquina C. Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean‐Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose deMiguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F. Stephen Hodi

    Published in Clinical and Translational Science (2024-06-01)
    Get full text
    Article


  10. 10

    A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors by Dejan Juric, Minal Barve, Ulka Vaishampayan, Desamparados Roda, Aitana Calvo, Noelia Martinez Jañez, Jose Trigo, Alastair Greystoke, R. Donald Harvey, Anthony J. Olszanski, Mateusz Opyrchal, Alexander Spira, Fiona Thistlethwaite, Begoña Jiménez, Jessica Huck Sappal, Karuppiah Kannan, Jason Riley, Cheryl Li, Cong Li, Richard C. Gregory, Harry Miao, Shining Wang

    Published in Cancer Medicine (2024-03-01)
    Get full text
    Article


Search Tools: